drugset / Trial / NCT00227474

S0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission

NCT00227474 ↗

Open-labelTreatment

Summary

RATIONALE: Vaccines made from a gene-modified virus may help the body build an effective immune response to kill tumor cells. Giving booster vaccinations may make a stronger immune response and prevent or delay the recurrence of cancer. PURPOSE: This phase II trial is studying how well vaccine therapy works in treating patients with stage IIIB or stage IV breast cancer in remission.

Timeline

Start
—
Primary completion
—
Completion
—

Outcome

Outcome not reported

Stopped: “SWOG has decided to not pursue this trial”

Drugs

EvaluationDrugModalityDoseRoute
Subject TroVax Vaccine — Intramuscular

Indications